@laukell's testosterone acne question, fact-checked
Quick answer
Transmasculine patients on testosterone therapy frequently experience acne, particularly in the first one to two years, driven primarily by DHT conversion in sebaceous glands rather than unstable testosterone levels directly. Standard first-line hormonal acne treatments like spironolactone carry anti-androgenic effects that may conflict with gender-affirming therapy goals, making dermatology referral and individualized treatment planning important. Options including topical retinoids and isotretinoin remain effective without interfering with masculinizing hormone therapy.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @laukell actually say?
@laukell is five years into testosterone therapy and, by their own account, loving it overall. But they're dealing with painful acne and frustrated by advice that keeps landing on "it's hormonal" as both the diagnosis and the dead end. They're asking two specific things: is an acne spike normal when you start testosterone, and why doesn't "it's hormonal" actually help when testosterone levels are the most stable variable in their body right now?
They're not making medical claims. They're asking genuine questions while visibly in pain. That honesty is worth acknowledging. This is a real gap in patient education around gender-affirming hormone therapy, and the frustration is completely warranted.
Does the science back this up?
Yes, and more specifically than most clinicians explain. Testosterone-related acne is well-documented in transmasculine patients, and the spike at initiation is real. A 2019 study by Chrisler et al. in Transgender Health and earlier survey data from the UCSF Center of Excellence for Transgender Health both found acne to be one of the most commonly reported dermatological side effects of testosterone therapy, particularly in the first one to two years.
The mechanism isn't simply "testosterone is high." Testosterone converts to dihydrotestosterone (DHT) via the enzyme 5-alpha reductase in sebaceous glands. DHT is the real driver, stimulating sebum overproduction. So someone on a consistent testosterone dose can still have fluctuating DHT and sebum activity depending on enzyme expression, receptor sensitivity, and other androgens in the system. That's exactly what @laukell is intuiting when they say the testosterone itself is stable but "everything else is a little bit wacky." They're right.
What did they get wrong (or right)?
They got the core observation right. Calling testosterone "the least varying" variable while other downstream effects remain unpredictable is actually a pretty accurate description of androgen biology. Serum testosterone can be stable while DHT conversion, receptor sensitivity, and sebum output fluctuate. That's not a contradiction, that's physiology.
What they got incomplete, not wrong, is the framing around "hormonal acne" advice being useless. Some of it is usable. Spironolactone is commonly used for hormonal acne in cisgender women, but it's an anti-androgen, which makes it complicated for someone on gender-affirming testosterone therapy since it can blunt masculinizing effects. That's a real clinical nuance that generic acne advice rarely flags.
Topical retinoids (tretinoin), oral antibiotics, and isotretinoin (Accutane) are all options that don't interfere with testosterone therapy. A 2021 review by Yeung et al. in the Journal of the American Academy of Dermatology specifically addressed acne management in transgender patients and noted that isotretinoin is often underutilized in this population despite being highly effective.
What should you actually know?
If you're on testosterone and dealing with acne, here's what the evidence actually supports. First, the spike is real and common, but it doesn't necessarily last years. Most studies suggest peak acne incidence is within the first year or two of therapy. Second, dermatology referral is appropriate and not an overreaction. Acne in this context is a medical issue, not a cosmetic one, especially when it's painful.
Third, not all acne treatments are created equal for this population. Spironolactone is often the first-line recommendation for hormonal acne in cisgender patients, but it carries androgen-blocking effects that may conflict with transition goals. Tretinoin, azelaic acid, and isotretinoin do not have that issue. Fourth, dose adjustments to testosterone are sometimes considered by endocrinologists, though they come with their own tradeoffs and should never be self-managed. Talk to a provider who has actual experience with gender-affirming care.
Is there anything the platform ecosystem gets wrong here?
Yes. A lot of acne content aimed at transmasculine people on TikTok either ignores the DHT mechanism entirely or recommends products designed for cisgender hormonal acne without flagging the anti-androgen issue. "Spearmint tea reduces androgens" is a genuinely common suggestion that floats around this space. For someone trying to masculinize, that is the last thing they want to do. That advice isn't neutral, it could actively work against someone's transition goals. Always verify acne advice with a provider who knows your full hormone picture.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @laukell's testosterone acne question, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@laukell's testosterone acne question, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Transmasculine patients on testosterone therapy frequently experience acne, particularly in the first one to two years, driven primarily by DHT conversion in sebaceous glands rather than unstable testosterone levels directly.
FormBlends verdict
Transmasculine patients on testosterone therapy frequently experience acne, particularly in the first one to two years, driven primarily by DHT conversion in sebaceous glands rather than unstable testosterone levels directly. Standard first-line hormonal acne treatments like spironolactone carry anti-androgenic effects that may conflict with gender-affirming therapy goals, making dermatology referral and individualized treatment planning important. Options including topical retinoids and isotretinoin remain effective without interfering with masculinizing hormone therapy.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Transmasculine patients on testosterone therapy frequently experience acne, particularly in the first one to two years, driven primarily by DHT conversion in sebaceous glands rather than unstable testosterone levels directly. Standard first-line hormonal acne treatments like spironolactone carry anti-androgenic effects that may conflict with gender-affirming therapy goals, making dermatology referral and individualized treatment planning important. Options including topical retinoids and isotretinoin remain effective without interfering with masculinizing hormone therapy.
- Acne affects an estimated 40-50% of transmasculine patients starting testosterone, based on observational cohort data from UCSF gender health programs, and is most common in the first one to two years of therapy.
- DHT, not testosterone directly, drives sebaceous gland activity. Stable testosterone doses do not prevent fluctuating DHT levels, which is why acne can persist even when T levels are consistent.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Acne affects an estimated 40-50% of transmasculine patients starting testosterone, based on observational cohort data from UCSF gender health programs, and is most common in the first one to two years of therapy.
- DHT, not testosterone directly, drives sebaceous gland activity. Stable testosterone doses do not prevent fluctuating DHT levels, which is why acne can persist even when T levels are consistent.
- Spironolactone, the most common first-line hormonal acne treatment, is an anti-androgen and may reduce masculinizing effects. It requires careful discussion with a provider familiar with gender-affirming care before use.
- Isotretinoin (Accutane) and topical retinoids like tretinoin do not interfere with testosterone therapy and are supported by evidence as effective options for androgen-driven acne in transmasculine patients (Yeung et al., 2021, JAAD).
- Spearmint tea and similar anti-androgen supplements circulating on social media as acne remedies could work against transition goals for someone on testosterone. These recommendations require clinical context that generic acne content does not provide.
- Painful inflammatory or cystic acne warrants dermatology referral, not just over-the-counter management. A provider experienced in gender-affirming care can coordinate treatment that doesn't conflict with hormone therapy goals.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
laukell · TikTok creator
17.6K views on this video
literally any advice welcome #acne #testosterone #trans #ftm #hormonalacne
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by laukell, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.